On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia

Progress in Neurobiology

Volumn 95, Issue 4, 2011, Pages 649-662

  Geser, F ^a   Prvulovic, D ^a   O'Dwyer, L ^a   Hardiman, O ^b   Bede, P ^b   Bokde, A L W ^c   Trojanowski, J Q ^d   Hampel, H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b BEAUMONT HOSPITAL   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

" Two axes" model; Amyotrophic lateral sclerosis; Biomarker; Frontotemporal lobar degeneration; TDP 43

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; TAR DNA BINDING PROTEIN; TAU PROTEIN; UBIQUITIN;

AMYOTROPHIC LATERAL SCLEROSIS; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; DEMENTIA; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOTOR NEURON DISEASE; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

AMYOTROPHIC LATERAL SCLEROSIS; DEMENTIA; DNA-BINDING PROTEINS; HUMANS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL;

EID: 82755189310     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2011.08.011     Document Type: Review

References (221)

1. Agosta F., Chiò A., Cosottini M., De Stefano N., Falini A., Mascalchi M., Rocca M.A., Silani V., Tedeschi G., Filippi M. The present and the future of neuroimaging in amyotrophic lateral sclerosis. Am. J. Neuroradiol. 2010, 31:1769-1777.
2. Amador-Ortiz C., Lin W.-L., Ahmed Z., Personett D., Davies P., Duara R., Graff-Radford N.R., Hutton M.L., Dickson D.W. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 2007, 61:435-445.
3. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351:602-611.
4. Arai T., Mackenzie I.R.A., Hasegawa M., Nonoka T., Niizato K., Tsuchiya K., Iritani S., Onaya M., Akiyama H. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol. 2009, 117:125-136.
5. Armstrong R.A., Lantos P.L., Cairns N.J. Overlap between neurodegenerative disorders. Neuropathology 2005, 25:111-124.
6. Armstrong R.A., Gearing M., Bigio E.H., Cruz-Sanchez F.F., Duyckaerts C., Mackenzie I.R.A., Perry R.H., Skullerud K., Yokoo H., Cairns N.J. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease. Acta Neuropathol. 2011, 121:219-228.
7. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B., Feldman H., Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919.
8. Banks G.T., Kuta A., Isaacs A.M., Fisher E.M.C. TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander. Mamm. Genome 2008, 19:299-305.
9. Bäumer D., Hilton D., Paine S.M.L., Turner M.R., Lowe J., Talbot K., Ansorge O. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 2010, 75:611-618.
10. Belzil V.V., Daoud H., St-Onge J., Desjarlais A., Bouchard J.-P., Dupre N., Lacomblez L., Salachas F., Pradat P.-F., Meininger V., Camu W., Dion P.A., Rouleau G.A. Identification of novel FUS mutations in sporadic cases of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2011, 12:113-117.
11. Benajiba L., Le Ber I., Camuzat A., Lacoste M., Thomas-Anterion C., Couratier P., Legallic S., Salachas F., Hannequin D., Decousus M., Lacomblez L., Guedj E., Golfier V., Camu W., Dubois B., Campion D., Meininger V., Brice A. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann. Neurol. 2009, 65:470-473.
12. Bigio E.H., Mishra M., Hatanpaa K.J., White C.L., Johnson N., Rademaker A., Weitner B.B., Deng H.-X., Dubner S.D., Weintraub S., Mesulam M. TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathol. 2010, 120:43-54.
13. Bilic E., Bilic E., Rudan I., Kusec V., Zurak N., Delimar D., Zagar M. Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls. Eur. J. Neurol. 2006, 13:1340-1345.
14. Blair I.P., Williams K.L., Warraich S.T., Durnall J.C., Thoeng A.D., Manavis J., Blumbergs P.C., Vucic S., Kiernan M.C., Nicholson G.A. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J. Neurol. Neurosurg. Psychiatry 2010, 81:639-645.
15. Borroni B., Bonvicini C., Alberici A., Buratti E., Agosti C., Archetti S., Papetti A., Stuani C., Di Luca M., Gennarelli M., Padovani A. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum. Mutat. 2009, 30:E974-E983.
16. Borroni B., Archetti S., Del Bo R., Papetti A., Buratti E., Bonvicini C., Agosti C., Cosseddu M., Turla M., Di Lorenzo D., Pietro Comi G., Gennarelli M., Padovani A. TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. Rejuvenation Res. 2010, 13:509-517.
17. Bowser R., Lacomis D. Applying proteomics to the diagnosis and treatment of ALS and related diseases. Muscle Nerve 2009, 40:753-762.
18. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
19. Braak H., Del Tredici K. Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation. Neurobiol. Aging 2004, 25:713-718. (discussion 743-746).
20. Braak H., Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol. 2011, 121:171-181.
21. Braak H., Del Tredici K., Rüb U., de Vos R.A.I., Jansen Steur E.N.H., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
22. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006, 112:389-404.
23. Braak H., Ludolph A., Thal D.R., Del Tredici K. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord. Acta Neuropathol. 2010, 120:67-74.
24. Brandmeir N.J., Geser F., Kwong L.K., Zimmerman E., Qian J., Lee V.M.-Y., Trojanowski J.Q. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol. 2008, 115:123-131.
25. Brettschneider J., Petzold A., Süssmuth S.D., Ludolph A.C., Tumani H. Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 2006, 66:852-856.
26. Brettschneider J., Widl K., Schattauer D., Ludolph A.C., Tumani H. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis. Neurosci. Lett. 2007, 416:257-260.
27. Brettschneider J., Mogel H., Lehmensiek V., Ahlert T., Süssmuth S., Ludolph A.C., Tumani H. Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS). Neurochem. Res. 2008, 33:2358-2363.
28. Broe M., Hodges J.R., Schofield E., Shepherd C.E., Kril J.J., Halliday G.M. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 2003, 60:1005-1011.
29. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. Sci. 1994, 124(Suppl.):96-107.
30. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. Other Motor Neuron Disord. 2000, 1:293-299.
31. Broustal O., Camuzat A., Guillot-Noël L., Guy N., Millecamps S., Deffond D., Lacomblez L., Golfier V., Hannequin D., Salachas F., Camu W., Didic M., Dubois B., Meininger V., Le Ber I., Brice A. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. J. Alzheimers Dis. 2010, 22:765-769.
32. Bruyn R.P., Koelman J.H., Troost D., de Jong J.M. Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 1995, 58:742-744.
33. Buratti E., Baralle F.E. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci. 2008, 13:867-878.
34. Burrell J.R., Kiernan M.C., Vucic S., Hodges J.R. Motor Neuron dysfunction in frontotemporal dementia. Brain 2011, 134:2582-2594.
35. Cairns N.J., Neumann M., Bigio E.H., Holm I.E., Troost D., Hatanpaa K.J., Foong C., White C.L., Schneider J.A., Kretzschmar H.A., Carter D., Taylor-Reinwald L., Paulsmeyer K., Strider J., Gitcho M., Goate A.M., Morris J.C., Mishra M., Kwong L.K., Stieber A., Xu Y., Forman M.S., Trojanowski J.Q., Lee V.M.-Y., Mackenzie I.R.A. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 2007, 171:227-240.
36. Chen Y.-Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M.L., Rabin B.A., Nicholson G.A., Auer-Grumbach M., Wagner K., De Jonghe P., Griffin J.W., Fischbeck K.H., Timmerman V., Cornblath D.R., Chance P.F. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 2004, 74:1128-1135.
37. Chen-Plotkin A.S., Geser F., Plotkin J.B., Clark C.M., Kwong L.K., Yuan W., Grossman M., Van Deerlin V.M., Trojanowski J.Q., Lee V.M.-Y. Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration. Hum. Mol. Genet. 2008, 17:1349-1362.
38. Chen-Plotkin A.S., Lee V.M.-Y., Trojanowski J.Q. TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 2010, 6:211-220.
39. Chen-Plotkin A.S., Xiao J., Geser F., Martinez-Lage M., Grossman M., Unger T., Wood E.M., Van Deerlin V.M., Trojanowski J.Q., Lee V.M.-Y. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration. Acta Neuropathol. 2010, 119:111-122.
40. Chen-Plotkin A.S., Martinez-Lage M., Sleiman P.M.A., Hu W., Greene R., et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch. Neurol. 2011, 68:488-497.
41. Chiò A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G. Prognostic factors in ALS: a critical review. Amyotroph. Lateral Scler. 2009, 10:310-323.
42. Chiò A., Schymick J.C., Restagno G., Scholz S.W., Lombardo F., Lai S.L., Mora G., Fung H.C., Britton A., Arepalli S., Gibbs J.R., Nalls M., Berger S., Kwee L.C., Oddone E.Z., Ding J., Crews C., Rafferty I., Washecka N., Hernandez D., Ferrucci L., Bandinelli S., Guralnik J., Macciardi F., Torri F., Lupoli S., Chanock S.J., Thomas G., Hunter D.J., Gieger C., Wichmann H.E., Calvo A., Mutani R., Battistini S., Giannini F., Caponnetto C., Mancardi G.L., La Bella V., Valentino F., Monsurrò M.R., Tedeschi G., Marinou K., Sabatelli M., Conte A., Mandrioli J., Sola P., Salvi F., Bartolomei I., Siciliano G., Carlesi C., Orrell R.W., Talbot K., Simmons Z., Connor J., Pioro E.P., Dunkley T., Stephan D.A., Kasperaviciute D., Fisher E.M., Jabonka S., Sendtner M., Beck M., Bruijn L., Rothstein J., Schmidt S., Singleton A., Hardy J., Traynor B.J. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2009, 18:1524-1532.
43. Chiò A., Calvo A., Moglia C., Restagno G., Ossola I., Brunetti M., Montuschi A., Cistaro A., Ticca A., Traynor B.J., Schymick J.C., Mutani R., Marrosu M.G., Murru M.R., Borghero G. Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutations. Arch. Neurol. 2010, 67:1002-1009.
44. Chou S.M., Norris F.H. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve 1993, 16:864-869.
45. Clinton L.K., Blurton-Jones M., Myczek K., Trojanowski J.Q., LaFerla F.M. Synergistic Interactions between abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J. Neurosci. 2010, 30:7281-7289.
46. Cohen T.J., Lee V.M.Y., Trojanowski J.Q. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol. Med. 2011.
47. Corrado L., Ratti A., Gellera C., Buratti E., Castellotti B., Carlomagno Y., Ticozzi N., Mazzini L., Testa L., Taroni F., Baralle F.E., Silani V., D'Alfonso S. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis. Hum. Mutat. 2009, 30:688-694.
48. Cruts M., Gijselinck I., Van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.-J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442:920-924.
49. Daoud H., Valdmanis P.N., Kabashi E., Dion P., Dupré N., Camu W., Meininger V., Rouleau G.A. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J. Med. Genet. 2009, 46:112-114.
50. Davidson Y., Amin H., Kelley T., Shi J., Tian J., Kumaran R., Lashley T., Lees A.J., DuPlessis D., Neary D., Snowden J., Akiyama H., Arai T., Hasegawa M., Bandopadhyay R., Sikkink S., Pickering-Brown S., Mann D.M.A. TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing. Acta Neuropathol. 2009, 118:359-369.
51. De Marco G., Lupino E., Calvo A., Moglia C., Buccinnà B., Grifoni S., Ramondetti C., Lomartire A., Rinaudo M.T., Piccinini M., Giordana M.T., Chiò A. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. Acta Neuropathol. 2011, 121:611-622.
52. DeJesus-Hernandez M., Kocerha J., Finch N., Crook R., Baker M., Desaro P., Johnston A., Rutherford N., Wojtas A., Kennelly K., Wszolek Z.K., Graff-Radford N., Boylan K., Rademakers R. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum. Mutat. 2010, 31:E1377-1389.
53. Del Bo R., Ghezzi S., Corti S., Pandolfo M., Ranieri M., Santoro D., Ghione I., Prelle A., Orsetti V., Mancuso M., Sorarù G., Briani C., Angelini C., Siciliano G., Bresolin N., Comi G.P. TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations. Eur. J. Neurol. 2009, 16:727-732.
54. Del Tredici K., Rüb U., De Vos R.A.I., Bohl J.R.E., Braak H. Where does parkinson disease pathology begin in the brain?. J. Neuropathol. Exp. Neurol. 2002, 61:413-426.
55. Deng H.-X., Zhai H., Bigio E.H., Yan J., Fecto F., Ajroud K., Mishra M., Ajroud-Driss S., Heller S., Sufit R., Siddique N., Mugnaini E., Siddique T. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 2010, 67:739-748.
56. Deng H.-X., Chen W., Hong S.-T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., Jiang H., Hirano M., Rampersaud E., Jansen G.H., Donkervoort S., Bigio E.H., Brooks B.R., Ajroud K., Sufit R.L., Haines J.L., Mugnaini E., Pericak-Vance M.A., Siddique T. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011.
57. Dickson D.W., Josephs K.A., Amador-Ortiz C. TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol. 2007, 114:71-79.
58. Dunckley T., Huentelman M.J., Craig D.W., Pearson J.V., Szelinger S., Joshipura K., Halperin R.F., Stamper C., Jensen K.R., Letizia D., Hesterlee S.E., Pestronk A., Levine T., Bertorini T., Graves M.C., Mozaffar T., Jackson C.E., Bosch P., McVey A., Dick A., Barohn R., Lomen-Hoerth C., Rosenfeld J., O'connor D.T., Zhang K., Crook R., Ryberg H., Hutton M., Katz J., Simpson E.P., Mitsumoto H., Bowser R., Miller R.G., Appel S.H., Stephan D.A. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N. Engl. J. Med. 2007, 357:775-788.
59. Elden A.C., Kim H.-J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., Padmanabhan A., Clay-Falcone D., McCluskey L., Elman L., Juhr D., Gruber P.J., Rüb U., Auburger G., Trojanowski J.Q., Lee V.M.-Y., Van Deerlin V.M., Bonini N.M., Gitler A.D. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010, 466:1069-1075.
60. Farrer M.J., Hulihan M.M., Kachergus J.M., Dächsel J.C., Stoessl A.J., Grantier L.L., Calne S., Calne D.B., Lechevalier B., Chapon F., Tsuboi Y., Yamada T., Gutmann L., Elibol B., Bhatia K.P., Wider C., Vilariño-Güell C., Ross O.A., Brown L.A., Castanedes-Casey M., Dickson D.W., Wszolek Z.K. DCTN1 mutations in Perry syndrome. Nat. Genet. 2009, 41:163-165.
61. Forman M.S., Farmer J., Johnson J.K., Clark C.M., Arnold S.E., Coslett H.B., Chatterjee A., Hurtig H.I., Karlawish J.H., Rosen H.J., Van Deerlin V., Lee V.M.-Y., Miller B.L., Trojanowski J.Q., Grossman M. Frontotemporal dementia: clinicopathological correlations. Ann. Neurol. 2006, 59:952-962.
62. Foulds P., McAuley E., Gibbons L., Davidson Y., Pickering-Brown S.M., Neary D., Snowden J.S., Allsop D., Mann D.M.A. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol. 2008, 116:141-146.
63. Foulds P.G., Davidson Y., Mishra M., Hobson D.J., Humphreys K.M., Taylor M., Johnson N., Weintraub S., Akiyama H., Arai T., Hasegawa M., Bigio E.H., Benson F.E., Allsop D., Mann D.M.A. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol. 2009, 118:647-658.
64. Freeman S.H., Spires-Jones T., Hyman B.T., Growdon J.H., Frosch M.P. TAR-DNA binding protein 43 in Pick disease. J. Neuropathol. Exp. Neurol. 2008, 67:62-67.
65. Fujishiro H., Uchikado H., Arai T., Hasegawa M., Akiyama H., Yokota O., Tsuchiya K., Togo T., Iseki E., Hirayasu Y. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease. Acta Neuropathol. 2009, 117:151-158.
66. Gendron T.F., Josephs K.A., Petrucelli L. Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration. Neuropathol. Appl. Neurobiol. 2010, 36:97-112.
67. Geser F., Brandmeir N.J., Kwong L.K., Martinez-Lage M., Elman L., McCluskey L., Xie S.X., Lee V.M.-Y., Trojanowski J.Q. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch. Neurol. 2008, 65:636-641.
68. Geser F., Winton M.J., Kwong L.K., Xu Y., Xie S.X., Igaz L.M., Garruto R.M., Perl D.P., Galasko D., Lee V.M.-Y., Trojanowski J.Q. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol. 2008, 115:133-145.
69. Geser F., Martinez-Lage M., Kwong L.K., Lee V.M.-Y., Trojanowski J.Q. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J. Neurol. 2009, 256:1205-1214.
70. Geser F., Martinez-Lage M., Robinson J., Uryu K., Neumann M., Brandmeir N.J., Xie S.X., Kwong L.K., Elman L., McCluskey L., Clark C.M., Malunda J., Miller B.L., Zimmerman E.A., Qian J., Van Deerlin V., Grossman M., Lee V.M.-Y., Trojanowski J.Q. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch. Neurol. 2009, 66:180-189.
71. Geser F., Lee V.M.-Y., Trojanowski J.Q. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology 2010, 30:103-112.
72. Geser F., Robinson J.L., Malunda J.A., Xie S.X., Clark C.M., Kwong L.K., Moberg P.J., Moore E.M., Van Deerlin V.M., Lee V.M.-Y., Arnold S.E., Trojanowski J.Q. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch. Neurol. 2010, 67:1238-1250.
73. Geser F., Malunda J.A., Hurtig H.I., Duda J.E., Wenning G.K., Gilman S., Low P.A., Lee V.M.-Y., Trojanowski J.Q. TDP-43 pathology occurs infrequently in multiple system atrophy. Neuropathol. Appl. Neurobiol. 2011, 37:358-365.
74. Geser F., Stein B., Partain M., Elman L.B., McCluskey L.F., Xie S.X., Van Deerlin V.M., Kwong L.K., Lee V.M.-Y., Trojanowski J.Q. Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathol. 2011, 121:509-517.
75. Gijselinck I., Sleegers K., Engelborghs S., Robberecht W., Martin J.-J., Vandenberghe R., Sciot R., Dermaut B., Goossens D., Van der Zee J., De Pooter T., Del-Favero J., Santens P., De Jonghe P., De Deyn P.P., Van Broeckhoven C., Cruts M. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol. Aging 2009, 30:1329-1331.
76. Giordana M.T., Piccinini M., Grifoni S., De Marco G., Vercellino M., Magistrello M., Pellerino A., Buccinnà B., Lupino E., Rinaudo M.T. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol. 2010, 20:351-360.
77. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., Morrison K.E., Green A., Acharya K.R., Brown R.H., Hardiman O. ANG mutations segregate with familial and "sporadic" amyotrophic lateral sclerosis. Nat. Genet. 2006, 38:411-413.
78. Grinberg L.T., Rüb U., Ferretti R.E.L., Nitrini R., Farfel J.M., Polichiso L., Gierga K., Jacob-Filho W., Heinsen H. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?. Neuropathol. Appl. Neurobiol. 2009, 35:406-416.
79. Grinberg L.T., Rueb U., Heinsen H. Brainstem: neglected locus in neurodegenerative diseases. Front. Neurol. 2011, 2:42.
80. Grossman M., Wood E.M., Moore P., Neumann M., Kwong L., Forman M.S., Clark C.M., McCluskey L.F., Miller B.L., Lee V.M.-Y., Trojanowski J.Q. TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch. Neurol. 2007, 64:1449-1454.
81. Habuchi C., Iritani S., Sekiguchi H., Torii Y., Ishihara R., Arai T., Hasegawa M., Tsuchiya K., Akiyama H., Shibayama H., Ozaki N. Clinicopathological study of diffuse neurofibrillary tangles with calcification. With special reference to TDP-43 proteinopathy and alpha-synucleinopathy. J. Neurol. Sci 2011, 301:77-85.
82. Hasegawa M., Arai T., Akiyama H., Nonaka T., Mori H., Hashimoto T., Yamazaki M., Oyanagi K. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 2007, 130:1386-1394.
83. Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F., Morita M., Nakano I., Oda T., Tsuchiya K., Akiyama H. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008, 64:60-70.
84. Hernandez Lain A., Millecamps S., Dubourg O., Salachas F., Bruneteau G., Lacomblez L., Leguern E., Seilhean D., Duyckaerts C., Meininger V., Mallet J., Pradat P.-F. Abnormal TDP-43 and FUS proteins in muscles of sporadic IBM: similarities in a TARDBP-linked ALS patient. J. Neurol. Neurosurg. Psychiatry 2010.
85. Higashi S., Iseki E., Yamamoto R., Minegishi M., Hino H., Fujisawa K., Togo T., Katsuse O., Uchikado H., Furukawa Y., Kosaka K., Arai H. Appearance pattern of TDP-43 in Japanese frontotemporal lobar degeneration with ubiquitin-positive inclusions. Neurosci. Lett. 2007, 419:213-218.
86. Higashi S., Iseki E., Yamamoto R., Minegishi M., Hino H., Fujisawa K., Togo T., Katsuse O., Uchikado H., Furukawa Y., Kosaka K., Arai H. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 2007, 1184:284-294.
87. Hodges J.R., Davies R., Xuereb J., Kril J., Halliday G. Survival in frontotemporal dementia. Neurology 2003, 61:349-354.
88. Holton J.L., Ghiso J., Lashley T., Rostagno A., Guerin C.J., Gibb G., Houlden H., Ayling H., Martinian L., Anderton B.H., Wood N.W., Vidal R., Plant G., Frangione B., Revesz T. Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am. J. Pathol. 2001, 158:515-526.
89. Hu W.T., Josephs K.A., Knopman D.S., Boeve B.F., Dickson D.W., Petersen R.C., Parisi J.E. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol. 2008, 116:215-220.
90. Hu W.T., Seelaar H., Josephs K.A., Knopman D.S., Boeve B.F., Sorenson E.J., McCluskey L., Elman L., Schelhaas H.J., Parisi J.E., Kuesters B., Lee V.M.-Y., Trojanowski J.Q., Petersen R.C., van Swieten J.C., Grossman M. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch. Neurol. 2009, 66:1359-1364.
91. Hu W.T., Chen-Plotkin A., Grossman M., Arnold S.E., Clark C.M., Shaw L.M., McCluskey L., Elman L., Hurtig H.I., Siderowf A., Lee V.M.-Y., Soares H., Trojanowski J.Q. Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology 2010, 75:2079-2086.
92. Huang E.J., Zhang J., Geser F., Trojanowski J.Q., Strober J.B., Dickson D.W., Brown R.H., Shapiro B.E., Lomen-Hoerth C. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol. 2010, 20:1069-1076.
93. Hudson A.J., Kiernan J.A., Munoz D.G., Pringle C.E., Brown W.F., Ebers G.C. Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis. Brain Res. Bull. 1993, 30:359-364.
94. Igaz L.M., Kwong L.K., Xu Y., Truax A.C., Uryu K., Neumann M., Clark C.M., Elman L.B., Miller B.L., Grossman M., McCluskey L.F., Trojanowski J.Q., Lee V.M.-Y. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 2008, 173:182-194.
95. Igaz L.M., Kwong L.K., Chen-Plotkin A., Winton M.J., Unger T.L., Xu Y., Neumann M., Trojanowski J.Q., Lee V.M.-Y. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies. J. Biol. Chem. 2009, 284:8516-8524.
96. Ince P.G., Evans J., Knopp M., Forster G., Hamdalla H.H.M., Wharton S.B., Shaw P.J. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003, 60:1252-1258.
97. Ishihara K., Ichikawa H., Suzuki Y., Shiota J., Nakano I., Kawamura M. Is lesion of Exner's area linked to progressive agraphia in amyotrophic lateral sclerosis with dementia? An autopsy case report. Behav. Neurol. 2010, 23:153-158.
98. Jellinger K.A., Seppi K., Wenning G.K. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov. Disord. 2005, 20(Suppl. 12):S29-S36.
99. Josephs K.A., Dickson D.W. Frontotemporal lobar degeneration with upper motor neuron disease/primary lateral sclerosis. Neurology 2007, 69:1800-1801.
100. Josephs K.A., Knopman D.S., Whitwell J.L., Boeve B.F., Parisi J.E., Petersen R.C., Dickson D.W. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology 2005, 65:645-647.
101. Josephs K.A., Whitwell J.L., Knopman D.S., Hu W.T., Stroh D.A., Baker M., Rademakers R., Boeve B.F., Parisi J.E., Smith G.E., Ivnik R.J., Petersen R.C., Jack C.R., Dickson D.W. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 2008, 70:1850-1857.
102. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.-P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.-F., Camu W., Meininger V., Dupre N., Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008, 40:572-574.
103. Kadokura A., Yamazaki T., Lemere C.A., Takatama M., Okamoto K. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology. Neuropathology 2009, 29:566-573.
104. Kamada M., Maruyama H., Tanaka E., Morino H., Wate R., Ito H., Kusaka H., Kawano Y., Miki T., Nodera H., Izumi Y., Kaji R., Kawakami H. Screening for TARDBP mutations in Japanese familial amyotrophic lateral sclerosis. J. Neurol. Sci. 2009, 284:69-71.
105. Kasai T., Tokuda T., Ishigami N., Sasayama H., Foulds P., Mitchell D.J., Mann D.M.A., Allsop D., Nakagawa M. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009, 117:55-62.
106. Kawajiri M., Mogi M., Higaki N., Tateishi T., Ohyagi Y., Horiuchi M., Miki T., Kira J.-I. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neurol. Scand. 2009, 119:341-344.
107. Kolarcik C., Bowser R. Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease. Mol. Diagn. Ther. 2006, 10:281-292.
108. Kovacs G.G., Murrell J.R., Horvath S., Haraszti L., Majtenyi K., Molnar M.J., Budka H., Ghetti B., Spina S. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov. Disord. 2009, 24:1843-1847.
109. Kovacs G.G., Botond G., Budka H. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics. Acta Neuropathol. 2010, 119:389-408.
110. Kril J.J., Halliday G.M. Pathological staging of frontotemporal lobar degeneration. J. Mol. Neurosci. 2011.
111. Kuhle J., Lindberg R.L.P., Regeniter A., Mehling M., Steck A.J., Kappos L., Czaplinski A. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur. J. Neurol. 2009, 16:771-774.
112. Kühnlein P., Sperfeld A.-D., Vanmassenhove B., Van Deerlin V., Lee V.M.-Y., Trojanowski J.Q., Kretzschmar H.A., Ludolph A.C., Neumann M. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch. Neurol. 2008, 65:1185-1189.
113. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R., Landers J.E., Brown R.H. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
114. Laaksovirta H., Peuralinna T., Schymick J.C., Scholz S.W., Lai S.-L., Myllykangas L., Sulkava R., Jansson L., Hernandez D.G., Gibbs J.R., Nalls M.A., Heckerman D., Tienari P.J., Traynor B.J. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol. 2010, 9:978-985.
115. Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: the FUS about TDP-43. Cell 2009, 136:1001-1004.
116. Le Ber I., Camuzat A., Berger E., Hannequin D., Laquerrière A., Golfier V., Seilhean D., Viennet G., Couratier P., Verpillat P., Heath S., Camu W., Martinaud O., Lacomblez L., Vercelletto M., Salachas F., Sellal F., Didic M., Thomas-Anterion C., Puel M., Michel B.-F., Besse C., Duyckaerts C., Meininger V., Campion D., Dubois B., Brice A. Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology 2009, 72:1669-1676.
117. Lee E.B., Lee V.M.-Y., Trojanowski J.Q., Neumann M. TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta Neuropathol. 2008, 115:305-311.
118. Lee T., Li Y.R., Chesi A., Hart M.P., Ramos D., Jethava N., Hosangadi D., Epstein J., Hodges B., Bonini N.M., Gitler A.D. Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology 2011, 76:2062-2065.
119. Lee T., Li Y.R., Ingre C., Weber M., Grehl T., Gredal O., de Carvalho M., Meyer T., Tysnes O.-B., Auburger G., Gispert S., Bonini N.M., Andersen P.M., Gitler A.D. Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum. Mol. Genet. 2011, 20:1697-1700.
120. Leigh P.N., Whitwell H., Garofalo O., Buller J., Swash M., Martin J.E., Gallo J.M., Weller R.O., Anderton B.H. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 1991, 114(Pt 2):775-788.
121. Lemmens R., Race V., Hersmus N., Matthijs G., Van Den Bosch L., Van Damme P., Dubois B., Boonen S., Goris A., Robberecht W. TDP-43 M311 V mutation in familial amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2009, 80:354-355.
122. Lin W.-L., Castanedes-Casey M., Dickson D.W. Transactivation response DNA-binding protein 43 microvasculopathy in frontotemporal degeneration and familial Lewy body disease. J. Neuropathol. Exp. Neurol. 2009, 68:1167-1176.
123. Mackenzie I.R.A., Rademakers R. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr. Opin. Neurol. 2008, 21:693-700.
124. Mackenzie I.R.A., Baborie A., Pickering-Brown S., Du Plessis D., Jaros E., Perry R.H., Neary D., Snowden J.S., Mann D.M.A. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol. 2006, 112:539-549.
125. Mackenzie I.R.A., Neumann M., Bigio E.H., Cairns N.J., Alafuzoff I., Kril J., Kovacs G.G., Ghetti B., Halliday G., Holm I.E., Ince P.G., Kamphorst W., Revesz T., Rozemuller A.J.M., Kumar-Singh S., Akiyama H., Baborie A., Spina S., Dickson D.W., Trojanowski J.Q., Mann D.M.A. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010, 119:1-4.
126. Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010, 9:995-1007.
127. Mackenzie I.R.A., Ansorge O., Strong M., Bilbao J., Zinman L., Ang L.-C., Baker M., Stewart H., Eisen A., Rademakers R., Neumann M. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation. Acta Neuropathol. 2011, 122:87-98.
128. Mackenzie I.R.A., Munoz D.G., Kusaka H., Yokota O., Ishihara K., Roeber S., Kretzschmar H.A., Cairns N.J., Neumann M. Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol. 2011, 121:207-218.
129. Mackenzie I.R.A., Neumann M., Baborie A., Sampathu D.M., Du Plessis D., Jaros E., Perry R.H., Trojanowski J.Q., Mann D.M.A., Lee V.M.Y. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011, 122:111-113.
130. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K., Suzuki N., Aoki M., Kawata A., Hirai T., Kato T., Ogasawara K., Hirano A., Takumi T., Kusaka H., Hagiwara K., Kaji R., Kawakami H. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223-226.
131. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M.Y., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
132. Miklossy J., Steele J.C., Yu S., McCall S., Sandberg G., McGeer E.G., McGeer P.L. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). Acta Neuropathol. 2008, 116:625-637.
133. Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet 2007, 369:2031-2041.
134. Mitchell R.M., Freeman W.M., Randazzo W.T., Stephens H.E., Beard J.L., Simmons Z., Connor J.R. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 2009, 72:14-19.
135. Mori F., Tanji K., Zhang H.-X., Nishihira Y., Tan C.-F., Takahashi H., Wakabayashi K. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008, 116:193-203.
136. Nakashima-Yasuda H., Uryu K., Robinson J., Xie S.X., Hurtig H., Duda J.E., Arnold S.E., Siderowf A., Grossman M., Leverenz J.B., Woltjer R., Lopez O.L., Hamilton R., Tsuang D.W., Galasko D., Masliah E., Kaye J., Clark C.M., Montine T.J., Lee V.M.-Y., Trojanowski J.Q. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007, 114:221-229.
137. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P.H., Albert M., Boone K., Miller B.L., Cummings J., Benson D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51:1546-1554.
138. Neumann M. Molecular neuropathology of TDP-43 proteinopathies. Int. J. Mol. Sci. 2009, 10:232-246.
139. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M.-Y. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
140. Neumann M., Mackenzie I.R., Cairns N.J., Boyer P.J., Markesbery W.R., Smith C.D., Taylor J.P., Kretzschmar H.A., Kimonis V.E., Forman M.S. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J. Neuropathol. Exp. Neurol. 2007, 66:152-157.
141. Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q., Lee V.M.-Y. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009, 117:137-149.
142. Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H.A., Mackenzie I.R.A. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009, 132:2922-2931.
143. Neumann M., Bentmann E., Dormann D., Jawaid A., Dejesus-Hernandez M., Ansorge O., Roeber S., Kretzschmar H.A., Munoz D.G., Kusaka H., Yokota O., Ang L.-C., Bilbao J., Rademakers R., Haass C., Mackenzie I.R.A. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 2011, 134:2595-2609.
144. Nishihira Y., Tan C.-F., Onodera O., Toyoshima Y., Yamada M., Morita T., Nishizawa M., Kakita A., Takahashi H. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008, 116:169-182.
145. Nishihira Y., Tan C.-F., Hoshi Y., Iwanaga K., Yamada M., Kawachi I., Tsujihata M., Hozumi I., Morita T., Onodera O., Nishizawa M., Kakita A., Takahashi H. Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology. Acta Neuropathol. 2009, 117:45-53.
146. Nishihira Y., Tan C.-F., Toyoshima Y., Yonemochi Y., Kondo H., Nakajima T., Takahashi H. Sporadic amyotrophic lateral sclerosis: widespread multisystem degeneration with TDP-43 pathology in a patient after long-term survival on a respirator. Neuropathology 2009, 29:689-696.
147. Noto Y.-I., Shibuya K., Sato Y., Kanai K., Misawa S., Sawai S., Mori M., Uchiyama T., Isose S., Nasu S., Sekiguchi Y., Fujimaki Y., Kasai T., Tokuda T., Nakagawa M., Kuwabara S. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value. Amyotroph. Lateral Scler. 2011, 12:140-143.
148. Nozaki I., Arai M., Takahashi K., Hamaguchi T., Yoshikawa H., Muroishi T., Noguchi-Shinohara M., Ito H., Itokawa M., Akiyama H., Kawata A., Yamada M. Familial ALS with G298S mutation in TARDBP: a comparison of CSF tau protein levels with those in sporadic ALS. Intern. Med. 2010, 49:1209-1212.
149. östberg P., Bogdanović N. Semantic dementia with lower motor neuron disease showing FTLD-TDP type 3 pathology (sensu Mackenzie). Neuropathology 2011, 31:271-279.
150. Olivé M., Janué A., Moreno D., Gámez J., Torrejón-Escribano B., Ferrer I. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies. J. Neuropathol. Exp. Neurol. 2009, 68:262-273.
151. Pamphlett R., Luquin N., McLean C., Jew S.K., Adams L. TDP-43 neuropathology is similar in sporadic amyotrophic lateral sclerosis with or without TDP-43 mutations. Neuropathol. Appl. Neurobiol. 2009, 35:222-225.
152. Pasinetti G.M., Ungar L.H., Lange D.J., Yemul S., Deng H., Yuan X., Brown R.H., Cudkowicz M.E., Newhall K., Peskind E., Marcus S., Ho L. Identification of potential CSF biomarkers in ALS. Neurology 2006, 66:1218-1222.
153. Pesiridis G.S., Lee V.M.-Y., Trojanowski J.Q. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 2009, 18:R156-R162.
154. Pradat P.-F., Dib M. Biomarkers in amyotrophic lateral sclerosis: facts and future horizons. Mol. Diagn. Ther. 2009, 13:115-125.
155. Pringle C.E., Hudson A.J., Munoz D.G., Kiernan J.A., Brown W.F., Ebers G.C. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992, 115(Pt 2):495-520.
156. Rademakers R., Stewart H., Dejesus-Hernandez M., Krieger C., Graff-Radford N., Fabros M., Briemberg H., Cashman N., Eisen A., Mackenzie I.R.A. Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis. Muscle Nerve 2010, 42:170-176.
157. Ranganathan S., Williams E., Ganchev P., Gopalakrishnan V., Lacomis D., Urbinelli L., Newhall K., Cudkowicz M.E., Brown R.H., Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 2005, 95:1461-1471.
158. Ravits J.M., La Spada A.R. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009, 73:805-811.
159. Robertson J., Bilbao J., Zinman L., Hazrati L.-N., Tokuhiro S., Sato C., Moreno D., Strome R., Mackenzie I.R., Rogaeva E. A novel double mutation in FUS gene causing sporadic ALS. Neurobiol. Aging 2011, 32. 553.e27-30.
160. Roeber S., Mackenzie I.R.A., Kretzschmar H.A., Neumann M. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Acta Neuropathol. 2008, 116:147-157.
161. Rohn T.T., Kokoulina P. Caspase-cleaved TAR DNA-binding protein-43 in Pick's disease. Int. J. Physiol. Pathophysiol. Pharmacol. 2009, 1:25-32.
162. Rohrer J.D., Geser F., Zhou J., Gennatas E.D., Sidhu M., Trojanowski J.Q., Dearmond S.J., Miller B.L., Seeley W.W. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology 2010, 75:2204-2211.
163. Rollinson S., Snowden J.S., Neary D., Morrison K.E., Mann D.M.A., Pickering-Brown S.M. TDP-43 gene analysis in frontotemporal lobar degeneration. Neurosci. Lett. 2007, 419:1-4.
164. Rollinson S., Rizzu P., Sikkink S., Baker M., Halliwell N., Snowden J., Traynor B.J., Ruano D., Cairns N., Rohrer J.D., Mead S., Collinge J., Rossor M., Akay E., Guerreiro R., Rademakers R., Morrison K.E., Pastor P., Alonso E., Martinez-Lage P., Graff-Radford N., Neary D., Heutink P., Mann D.M.A., Van Swieten J., Pickering-Brown S.M. Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration. Neurobiol. Aging 2009, 30:656-665.
165. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
166. Ross O.A., Rutherford N.J., Baker M., Soto-Ortolaza A.I., Carrasquillo M.M., Dejesus-Hernandez M., Adamson J., Li M., Volkening K., Finger E., Seeley W.W., Hatanpaa K.J., Lomen-Hoerth C., Kertesz A., Bigio E.H., Lippa C., Woodruff B.K., Knopman D.S., White C.L., Van Gerpen J.A., Meschia J.F., Mackenzie I.R., Boylan K., Boeve B.F., Miller B.L., Strong M.J., Uitti R.J., Younkin S.G., Graff-Radford N.R., Petersen R.C., Wszolek Z.K., Dickson D.W., Rademakers R. Ataxin-2 repeat-length variation and neurodegeneration. Hum. Mol. Genet. 2011, 20:3207-3212.
167. Rutherford N.J., Zhang Y.-J., Baker M., Gass J.M., Finch N.A., Xu Y.-F., Stewart H., Kelley B.J., Kuntz K., Crook R.J.P., Sreedharan J., Vance C., Sorenson E., Lippa C., Bigio E.H., Geschwind D.H., Knopman D.S., Mitsumoto H., Petersen R.C., Cashman N.R., Hutton M., Shaw C.E., Boylan K.B., Boeve B., Graff-Radford N.R., Wszolek Z.K., Caselli R.J., Dickson D.W., Mackenzie I.R., Petrucelli L., Rademakers R. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008, 4:e1000193.
168. Seilhean D., Cazeneuve C., Thuriès V., Russaouen O., Millecamps S., Salachas F., Meininger V., Leguern E., Duyckaerts C. Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Acta Neuropathol. 2009, 118:561-573.
169. Saito Y., Ruberu N.N., Sawabe M., Arai T., Tanaka N., Kakuta Y., Yamanouchi H., Murayama S. Staging of argyrophilic grains: an age-associated tauopathy. J. Neuropathol. Exp. Neurol. 2004, 63:911-918.
170. Sampathu D.M., Neumann M., Kwong L.K., Chou T.T., Micsenyi M., Truax A., Bruce J., Grossman M., Trojanowski J.Q., Lee V.M.-Y. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am. J. Pathol. 2006, 169:1343-1352.
171. Sanelli T., Xiao S., Horne P., Bilbao J., Zinman L., Robertson J. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007, 66:1147-1153.
172. Schumacher A., Friedrich P., Diehl-Schmid J., Ibach B., Perneczky R., Eisele T., Vukovich R., Foerstl H., Riemenschneider M. No association of TDP-43 with sporadic frontotemporal dementia. Neurobiol. Aging 2009, 30:157-159.
173. Schwab C., Arai T., Hasegawa M., Yu S., McGeer P.L. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J. Neuropathol. Exp. Neurol. 2008, 67:1159-1165.
174. Schwab C., Arai T., Hasegawa M., Akiyama H., Yu S., McGeer P.L. TDP-43 pathology in familial British dementia. Acta Neuropathol. 2009, 118:303-311.
175. Seelaar H., Schelhaas H.J., Azmani A., Küsters B., Rosso S., Majoor-Krakauer D., de Rijik M.C., Rizzu P., ten Brummelhuis M., van Doorn P.A., Kamphorst W., Willemsen R., van Swieten J.C. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. Brain 2007, 130:1375-1385.
176. Shatunov A., Mok K., Newhouse S., Weale M.E., Smith B., Vance C., Johnson L., Veldink J.H., van Es M.A., van den Berg L.H., Robberecht W., Van Damme P., Hardiman O., Farmer A.E., Lewis C.M., Butler A.W., Abel O., Andersen P.M., Fogh I., Silani V., Chiò A., Traynor B.J., Melki J., Meininger V., Landers J.E., McGuffin P., Glass J.D., Pall H., Leigh P.N., Hardy J., Brown R.H., Powell J.F., Orrell R.W., Morrison K.E., Shaw P.J., Shaw C.E., Al-Chalabi A. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol. 2010, 9:986-994.
177. Skovronsky D.M., Lee V.M.-Y., Trojanowski J.Q. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 2006, 1:151-170.
178. Sleegers K., Brouwers N., Maurer-Stroh S., van Es M.A., Van Damme P., van Vught P.W.J., Van der Zee J., Serneels S., De Pooter T., Van den Broeck M., Cruts M., Schymkowitz J., De Jonghe P., Rousseau F., van den Berg L.H., Robberecht W., Van Broeckhoven C. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology 2008, 71:253-259.
179. Sorarú G., Orsetti V., Buratti E., Baralle F., Cima V., Volpe M., D'ascenzo C., Palmieri A., Koutsikos K., Pegoraro E., Angelini C. TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010, 11:240-243.
180. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
181. Steinacker P., Hendrich C., Sperfeld A.D., Jesse S., von Arnim C.A.F., Lehnert S., Pabst A., Uttner I., Tumani H., Lee V.M.-Y., Trojanowski J.Q., Kretzschmar H.A., Ludolph A., Neumann M., Otto M. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch. Neurol. 2008, 65:1481-1487.
182. Strong M.J. The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2008, 9:323-338.
183. Strong M.J., Grace G.M., Freedman M., Lomen-Hoerth C., Woolley S., Goldstein L.H., Murphy J., Shoesmith C., Rosenfeld J., Leigh P.N., Bruijn L., Ince P., Figlewicz D. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2009, 10:131-146.
184. Süssmuth S.D., Brettschneider J., Ludolph A.C., Tumani H. Biochemical markers in CSF of ALS patients. Curr. Med. Chem. 2008, 15:1788-1801.
185. Tamaoka A., Arai M., Itokawa M., Arai T., Hasegawa M., Tsuchiya K., Takuma H., Tsuji H., Ishii A., Watanabe M., Takahashi Y., Goto J., Tsuji S., Akiyama H. TDP-43 M337 V mutation in familial amyotrophic lateral sclerosis in Japan. Intern. Med. 2010, 49:331-334.
186. Tan C.-F., Kakita A., Piao Y.-S., Kikugawa K., Endo K., Tanaka M., Okamoto K., Takahashi H. Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropathol. 2003, 105:615-620.
187. Tan C.-F., Yamada M., Toyoshima Y., Yokoseki A., Miki Y., Hoshi Y., Kaneko H., Ikeuchi T., Onodera O., Kakita A., Takahashi H. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease. Acta Neuropathol. 2009, 118:553-560.
188. Tartaglia M.C., Rowe A., Findlater K., Orange J.B., Grace G., Strong M.J. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch. Neurol. 2007, 64:232-236.
189. Thal D.R., Rüb U., Schultz C., Sassin I., Ghebremedhin E., Del Tredici K., Braak E., Braak H. Sequence of Abeta-protein deposition in the human medial temporal lobe. J. Neuropathol. Exp. Neurol. 2000, 59:733-748.
190. Thal D.R., Rüb U., Orantes M., Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.
191. Ticozzi N., Silani V., LeClerc A.L., Keagle P., Gellera C., Ratti A., Taroni F., Kwiatkowski T.J., McKenna-Yasek D.M., Sapp P.C., Brown R.H., Landers J.E. Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology 2009, 73:1180-1185.
192. Tsuchiya K., Sano M., Shiotsu H., Akiyama H., Watabiki S., Taki K., Kondo H., Nakano I., Ikeda K. Sporadic amyotrophic lateral sclerosis of long duration mimicking spinal progressive muscular atrophy exists: additional autopsy case with a clinical course of 19 years. Neuropathology 2004, 24:228-235.
193. Turner M.R., Kiernan M.C., Leigh P.N., Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009, 8:94-109.
194. Uryu K., Nakashima-Yasuda H., Forman M.S., Kwong L.K., Clark C.M., Grossman M., Miller B.L., Kretzschmar H.A., Lee V.M.-Y., Trojanowski J.Q., Neumann M. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J. Neuropathol. Exp. Neurol. 2008, 67:555-564.
195. Van Damme P., Veldink J.H., van Blitterswijk M., Corveleyn A., van Vught P.W.J., Thijs V., Dubois B., Matthijs G., van den Berg L.H., Robberecht W. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 2011, 76:2066-2072.
196. Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., Steinbart E., McCluskey L., Grossman M., Neumann M., Wu I.-L., Yang W.-S., Kalb R., Galasko D.R., Montine T.J., Trojanowski J.Q., Lee V.M.-Y., Schellenberg G.D., Yu C.-E. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008, 7:409-416.
197. Van Deerlin V.M., Sleiman P.M.A., Martinez-Lage M., Chen-Plotkin A., Wang L.-S., et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 2010, 42:234-239.
198. Van der Zee J., Van Langenhove T., Kleinberger G., Sleegers K., Engelborghs S., Vandenberghe R., Santens P., Van den Broeck M., Joris G., Brys J., Mattheijssens M., Peeters K., Cras P., De Deyn P.P., Cruts M., Van Broeckhoven C. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain 2011, 134:808-815.
199. Van Es M.A., Veldink J.H., Saris C.G.J., Blauw H.M., van Vught P.W.J., et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet. 2009, 41:1083-1087.
200. Vass R., Ashbridge E., Geser F., Hu W.T., Grossman M., Clay-Falcone D., Elman L., McCluskey L., Lee V.M.Y., Van Deerlin V.M., Trojanowski J.Q., Chen-Plotkin A.S. Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathol. 2011, 121:373-380.
201. Vidal R., Frangione B., Rostagno A., Mead S., Révész T., Plant G., Ghiso J. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999, 399:776-781.
202. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 1985, 44:559-577.
203. Wang I.-F., Wu L.-S., Shen C.-K.J. TDP-43: an emerging new player in neurodegenerative diseases. Trends Mol. Med. 2008, 14:479-485.
204. Weihl C.C., Temiz P., Miller S.E., Watts G., Smith C., Forman M., Hanson P.I., Kimonis V., Pestronk A. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatr. 2008, 79:1186-1189.
205. Wenning G.K., Quinn N., Magalhǎes M., Mathias C., Daniel S.E. Minimal change" multiple system atrophy. Mov. Disord. 1994, 9:161-166.
206. Wenning G.K., Seppi K., Tison F., Jellinger K. A novel grading scale for striatonigral degeneration (multiple system atrophy). J. Neural. Transm. 2002, 109:307-320.
207. Whitwell J.L., Jack C.R., Parisi J.E., Senjem M.L., Knopman D.S., Boeve B.F., Rademakers R., Baker M., Petersen R.C., Dickson D.W., Josephs K.A. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?. Neurology 2010, 75:2212-2220.
208. Wider C., Dickson D.W., Stoessl A.J., Tsuboi Y., Chapon F., Gutmann L., Lechevalier B., Calne D.B., Personett D.A., Hulihan M., Kachergus J., Rademakers R., Baker M.C., Grantier L.L., Sujith O.K., Brown L., Calne S., Farrer M.J., Wszolek Z.K. Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat. Disord. 2009, 15:281-286.
209. Williams K.L., Durnall J.C., Thoeng A.D., Warraich S.T., Nicholson G.A., Blair I.P. A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred. J. Neurol. Neurosurg. Psychiatr. 2009, 80:1286-1288.
210. Wilson A.C., Dugger B.N., Dickson D.W., Wang D.-S. TDP-43 in aging and Alzheimer's disease-a review. Int. J. Clin. Exp. Pathol. 2011, 4:147-155.
211. Winton M.J., Van Deerlin V.M., Kwong L.K., Yuan W., Wood E.M., Yu C.-E., Schellenberg G.D., Rademakers R., Caselli R., Karydas A., Trojanowski J.Q., Miller B.L., Lee V.M.-Y. A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro. FEBS Lett. 2008, 582:2252-2256.
212. Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q., Lee V.M.-Y. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 2008, 283:13302-13309.
213. Yamada M., Sato T., Tsuji S., Takahashi H. CAG repeat disorder models and human neuropathology: similarities and differences. Acta Neuropathol. 2008, 115:71-86.
214. Yan J., Deng H.-X., Siddique N., Fecto F., Chen W., Yang Y., Liu E., Donkervoort S., Zheng J.G., Shi Y., Ahmeti K.B., Brooks B., Engel W.K., Siddique T. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology 2010, 75:807-814.
215. Yokoseki A., Shiga A., Tan C.-F., Tagawa A., Kaneko H., Koyama A., Eguchi H., Tsujino A., Ikeuchi T., Kakita A., Okamoto K., Nishizawa M., Takahashi H., Onodera O. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 2008, 63:538-542.
216. Yokota O., Davidson Y., Arai T., Hasegawa M., Akiyama H., Ishizu H., Terada S., Sikkink S., Pickering-Brown S., Mann D.M.A. Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease. Acta Neuropathol. 2010, 120:789-801.
217. Yokota O., Davidson Y., Bigio E.H., Ishizu H., Terada S., Arai T., Hasegawa M., Akiyama H., Sikkink S., Pickering-Brown S., Mann D.M.A. Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol. 2010, 120:55-66.
218. Yu C.-E., Bird T.D., Bekris L.M., Montine T.J., Leverenz J.B., Steinbart E., Galloway N.M., Feldman H., Woltjer R., Miller C.A., Wood E.M., Grossman M., McCluskey L., Clark C.M., Neumann M., Danek A., Galasko D.R., Arnold S.E., Chen-Plotkin A., Karydas A., Miller B.L., Trojanowski J.Q., Lee V.M.-Y., Schellenberg G.D., Van Deerlin V.M. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch. Neurol. 2010, 67:161-170.
219. Yu Z., Zhu Y., Chen-Plotkin A.S., Clay-Falcone D., McCluskey L., Elman L., Kalb R.G., Trojanowski J.Q., Lee V.M.-Y., Van Deerlin V.M., Gitler A.D., Bonini N.M. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats. PLoS ONE 2011, 6:e17951.
220. Zetterberg H., Jacobsson J., Rosengren L., Blennow K., Andersen P.M. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype. Eur. J. Neurol. 2007, 14:1329-1333.
221. Zhang H., Tan C.-F., Mori F., Tanji K., Kakita A., Takahashi H., Wakabayashi K. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008, 115:115-122.